Guggenheim Capital LLC Icad Inc Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.53 - $7.0 $221,888 - $342,874	-48,982 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.65 - $6.05 $414,618 - $687,243	-113,594 Reduced 69.87%	48,982 $253,000
Q4 2018 Feb 14, 2019	SELL	$2.54 - $4.34 $94,350 - $161,213	-37,146 Reduced 18.6%	162,576 $601,000
Q2 2018 Aug 14, 2018	SELL	$3.04 - $3.93 $11,752 - $15,193	-3,866 Reduced 1.9%	199,722 $610,000
Q1 2018 May 15, 2018	BUY	$2.96 - $4.0 $68 - $92	23 Added 0.01%	203,588 $628,000
Q4 2017 Feb 14, 2018	BUY	$3.38 - $4.74 $39,393 - $55,244	11,655 Added 6.07%	203,565 $700,000
Q3 2017 Nov 14, 2017	BUY	$3.3 - $4.42 $633,303 - $848,242	191,910	191,910 $847,000

5.92M

1.5K

20.4K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $39.5M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.